Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classifica tra le azioni #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Prezzo delle azioni
$71.46
Capitalizzazione di mercato
$29.96B
Variazione (1 giorno)
-0.04%
Variazione (1 anno)
-51.01%
Paese
US
Scambia Zoetis Inc. (ZTS)

Categoria

Healthcare
Numero di azioni in circolazione per Zoetis Inc. (ZTS)
Numero di azioni in circolazione al June 2026: 417.60M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Zoetis Inc., il numero attuale di azioni in circolazione è 417.60M. Alla fine del December 2024, la società aveva 454.20M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Zoetis Inc. (ZTS) dal 2009 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
2026 (TTM) 417.60M -5.83%
2025 443.44M -2.37%
2024 454.20M -1.51%
2023 461.17M -1.65%
2022 468.89M -1.15%
2021 474.35M -0.24%
2020 475.50M -0.55%
2019 478.13M -1.02%
2018 483.06M -1.40%
2017 489.92M -1.17%
2016 495.72M -0.80%
2015 499.71M -0.27%
2014 501.06M 0.21%
2013 500.00M 0.00%
2012 500.00M 4.57%
2011 478.13M 0.00%
2010 478.13M 0.00%
2009 478.13M 0.00%
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 113.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 484.33%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 324.09%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 90.61%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US